Controversies in massive pulmonary embolism

Controversies in massive pulmonary embolism

Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista medíca de Chile 2013-04, Vol.141 (4), p.486-494
Hauptverfasser: Mercado, Marcelo, Aizman, Andrés, Andresen, Max
Format: Artikel
Sprache:spa
Schlagworte:
Humans
Pulmonary Embolism - diagnosis
Pulmonary Embolism - therapy
Thrombolytic Therapy - methods
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 494
container_issue 4
container_start_page 486
container_title Revista medíca de Chile
container_volume 141
creator Mercado, Marcelo
Aizman, Andrés
Andresen, Max
description Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.
doi_str_mv 10.4067/S0034-98872013000400010
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1416694125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1416694125</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-284f7119640d55d085cd4d02da87d3607690228a25dd87676121deff54fc6e33</originalsourceid><addsrcrecordid>eNo1T8tKxDAUDYI44-gvaJeCdLw37y6l-IKBWTj7kmlSiDRNbdoB_96A4-JwNudJyD3CloNUT58AjJeV1ooCMgDgGQgXZA0KVSlRshW5TukLgCqJ-oqsKKuyScGaPNZxmKd4clPyLhV-KIJJyZ9cMS59iIOZfgoXjrH3KdyQy870yd2eeUMOry-H-r3c7d8-6uddOSLHuaSadwqxkhysEBa0aC23QK3RyjIJSlZAqTZUWKuVzJMoWtd1gnetdIxtyMNf7DjF78WluQk-ta7vzeDikppcImXFkYosvTtLl2NwthknH_Li5v8f-wUmi0_z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1416694125</pqid></control><display><type>article</type><title>Controversies in massive pulmonary embolism</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mercado, Marcelo ; Aizman, Andrés ; Andresen, Max</creator><creatorcontrib>Mercado, Marcelo ; Aizman, Andrés ; Andresen, Max</creatorcontrib><description>Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.</description><identifier>EISSN: 0717-6163</identifier><identifier>DOI: 10.4067/S0034-98872013000400010</identifier><identifier>PMID: 23900370</identifier><language>spa</language><publisher>Chile</publisher><subject>Humans ; Pulmonary Embolism - diagnosis ; Pulmonary Embolism - therapy ; Thrombolytic Therapy - methods</subject><ispartof>Revista medíca de Chile, 2013-04, Vol.141 (4), p.486-494</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23900370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mercado, Marcelo</creatorcontrib><creatorcontrib>Aizman, Andrés</creatorcontrib><creatorcontrib>Andresen, Max</creatorcontrib><title>Controversies in massive pulmonary embolism</title><title>Revista medíca de Chile</title><addtitle>Rev Med Chil</addtitle><description>Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.</description><subject>Humans</subject><subject>Pulmonary Embolism - diagnosis</subject><subject>Pulmonary Embolism - therapy</subject><subject>Thrombolytic Therapy - methods</subject><issn>0717-6163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1T8tKxDAUDYI44-gvaJeCdLw37y6l-IKBWTj7kmlSiDRNbdoB_96A4-JwNudJyD3CloNUT58AjJeV1ooCMgDgGQgXZA0KVSlRshW5TukLgCqJ-oqsKKuyScGaPNZxmKd4clPyLhV-KIJJyZ9cMS59iIOZfgoXjrH3KdyQy870yd2eeUMOry-H-r3c7d8-6uddOSLHuaSadwqxkhysEBa0aC23QK3RyjIJSlZAqTZUWKuVzJMoWtd1gnetdIxtyMNf7DjF78WluQk-ta7vzeDikppcImXFkYosvTtLl2NwthknH_Li5v8f-wUmi0_z</recordid><startdate>201304</startdate><enddate>201304</enddate><creator>Mercado, Marcelo</creator><creator>Aizman, Andrés</creator><creator>Andresen, Max</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201304</creationdate><title>Controversies in massive pulmonary embolism</title><author>Mercado, Marcelo ; Aizman, Andrés ; Andresen, Max</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-284f7119640d55d085cd4d02da87d3607690228a25dd87676121deff54fc6e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2013</creationdate><topic>Humans</topic><topic>Pulmonary Embolism - diagnosis</topic><topic>Pulmonary Embolism - therapy</topic><topic>Thrombolytic Therapy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mercado, Marcelo</creatorcontrib><creatorcontrib>Aizman, Andrés</creatorcontrib><creatorcontrib>Andresen, Max</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista medíca de Chile</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mercado, Marcelo</au><au>Aizman, Andrés</au><au>Andresen, Max</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Controversies in massive pulmonary embolism</atitle><jtitle>Revista medíca de Chile</jtitle><addtitle>Rev Med Chil</addtitle><date>2013-04</date><risdate>2013</risdate><volume>141</volume><issue>4</issue><spage>486</spage><epage>494</epage><pages>486-494</pages><eissn>0717-6163</eissn><abstract>Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.</abstract><cop>Chile</cop><pmid>23900370</pmid><doi>10.4067/S0034-98872013000400010</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 0717-6163
ispartof Revista medíca de Chile, 2013-04, Vol.141 (4), p.486-494
issn 0717-6163
language spa
recordid cdi_proquest_miscellaneous_1416694125
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Humans
Pulmonary Embolism - diagnosis
Pulmonary Embolism - therapy
Thrombolytic Therapy - methods
title Controversies in massive pulmonary embolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T12%3A29%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Controversies%20in%20massive%20pulmonary%20embolism&rft.jtitle=Revista%20med%C3%ADca%20de%20Chile&rft.au=Mercado,%20Marcelo&rft.date=2013-04&rft.volume=141&rft.issue=4&rft.spage=486&rft.epage=494&rft.pages=486-494&rft.eissn=0717-6163&rft_id=info:doi/10.4067/S0034-98872013000400010&rft_dat=%3Cproquest_pubme%3E1416694125%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1416694125&rft_id=info:pmid/23900370&rfr_iscdi=true